Skip to main content

GEN Announces Phase 2 Trial Results of GN-037 Topical Cream

| deneme | No Comments
As GEN, we announced the positive results of the Phase 2 clinical…

GEN Won the Bronze Award from the 2024 Brandon Hall Group HCM Excellence Awards®!

| 2024 | No Comments
GEN Won the Bronze Award from the 2024 Brandon Hall Group HCM…

GEN Once Again on the Fortune 500 Türkiye List!

| Uncategorized | No Comments
GEN Once Again on the Fortune 500 Türkiye List! We are ranked…

GEN has signed an important partnership and collaboration agreement with Jaguar Health Inc.

| Uncategorized | No Comments
GEN has signed an important partnership and collaboration agreement with Jaguar Health.…

GEN initiates Phase 1 study of the first-in-class investigational drug SUL-238

| 2024, 2024, 2024, 2024 | No Comments
GEN initiates Phase 1 study of the first-in-class investigational drug SUL-238 Ankara,…

GEN is on the Fortune 500 Türkiye List!

| 2023 | No Comments
As one of Türkiye's fastest-growing pharmaceutical companies, we are pleased to be…

GEN at CPHI Barcelona 2023!

| Uncategorized | No Comments
GEN at CPHI Barcelona 2023! We will be at CPhI, the largest…

GEN Sustainability Report Has Been Published!

| Uncategorized | No Comments
GEN 2022 Sustainability Report has been published in accordance with GRI standards.…

GEN Azerbaijan Manufacturing Facility Agreement!

| Uncategorized | No Comments
We are pleased to announce that we have signed a new agreement…

Phase-1 Results of GN-037 Topical Cream!

| 2023, 2023, 2023, 2023, 2023 | No Comments
Our company Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN)…

We Have Become a Member of Global Compact Türkiye!

| Uncategorized | No Comments
We are delighted to announce that as GEN, we have become a…

ETİKA Most Ethical Companies of the Year Awards found their owners!

| 2022 | No Comments
GEN was deemed worthy of the ETİKA award by being one of…

GEN is on the Capital 500 List!

| 2022, 2022, 2022, 2022, 2022 | No Comments
GEN is on the Capital 500 List! “We are pleased to be…

GEN is on the Fortune 500 List!

| Uncategorized | No Comments
As one of Turkey's fastest growing pharmaceutical companies, we are happy to…

We have signed a Local Representative & Services Agreement with MODERNA.

| Uncategorized | No Comments
We have signed a Local Representative and Services Agreement with MODERNA. Under…

We Have Become a Shareholder of Neo Auvra.

| Uncategorized | No Comments
As a result of the search for new products, new production-sales-distribution relations/regions,…

Our manufacturing facility has received EU GMP approval from Germany.

| 2021, 2021, 2021, 2021, 2021, 2021 | No Comments
GEN has received European Union Good Manufacturing Practices (EU GMP) approval, which…

GEN is investing in a biotechnology start-up RS Research, developing novel drugs for cancer patients

| Uncategorized | No Comments
GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GEN), a leading…

We Are Included In TURQUALITY®

| Uncategorized | No Comments
We are included in the Turquality program, the first-ever state-funded branding program…

GEN and SULFATEQ Sign Definitive Collaboration Agreement

| Uncategorized | No Comments
SULFATEQ and GEN sign definitive collaboration agreement to develop a therapy for…

Partnership Between GEN and Albireo Pharma

| 2021 | No Comments
We are proud to announce that we have taken yet another important…

We Added Russian Market To Our Partnership With Pharmaxis

| Uncategorized | No Comments
As GEN, we continue to deliver our Rare Solutions around the globe.…

We Got Our Great Place To Work Certificate

| Uncategorized | No Comments
We got our Great Place To Work certificate. We value human life…

TUBITAK President Visits GEN’s Manufacturing Facility

| 2020 | No Comments
We are greatly pleased and honored to receive a visit to our…

Alnylam Pharmaceuticals and GEN Sign Distribution Agreement

| 2020 | No Comments
ZUG, Switzerland & ANKARA, Turkey--(BUSINESS WIRE)--Mar. 25, 2020-- Alnylam Pharmaceuticals, Inc. (Nasdaq:…

We Gained The Research and Development Center Status

| 2019 | No Comments
Another milestone for GEN in its mission to give the best service…